Global Pharma Companies Dominate Indian Vaccine Market: PharmaTrac Report
Pharma

Global Pharma Companies Dominate Indian Vaccine Market: PharmaTrac Report

New Delhi: Global pharmaceutical companies currently hold 60 percent of value share in India's vaccine market, marking a notable presence in the country's pharmaceutical landscape, according to data from research firm PharmaTrac, as reported by the Economic Times (ET). India's vaccine market, which faced challenges during the Covid-19 pandemic, is gradually rebounding, with multinational corporations (MNCs) resuming their growth trajectory, as indicated by PharmaTrac's findings. Although domestically manufactured vaccines are gradually gaining traction, certain vaccines continue to be dominated by MNCs. For instance, Pfizer's Prevenar 13, a pneumococcal vaccine, outperformed its Indian counterpart, Serum Institute of India's (SII) Pneumosil vaccine, with significantly higher revenue in January. Pfizer's Prevenar 13 generated Rs 61.3 crore in revenue, while SII generated Rs 21.2 crore....
Read More

 Jobs

Export Manager Required

Company Name:
Zota Healthcare Limited

Location:
Surat, Gujarat

Salary:
Negotiable

Experience required:
10 Years experience in the African & Asian market.

Regulatory Manager Required

Company Name:
Zota Healthcare Limited

Location:
Surat, Gujarat

Salary:
Negotiable

Experience required:
5 Years experience in the African & Asian market.

Export Manager Required

Company Name:
Meher Pharma International

Location:
Rohini, Delhi

Salary:
During training is 8000 per month and after confirmation 10000 per month.

Experience required:
12th pass freshers can apply.

UPCOMING EVENTS